Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-01-02 @ 9:47 AM
Study NCT ID:
NCT00005835
Status:
COMPLETED
Last Update Posted:
2023-04-10
First Post:
2000-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
N99-02: Melphalan and Buthionine Sulfoximine
Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000067849
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |